technetium tc 99m sestamibi has been researched along with simvastatin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lupattelli, G; Palumbo, B; Sinzinger, H | 1 |
Azevedo, ÍM; Carvalho, MD; Higuchi, T; Javadi, SM; Lima, FP; Macedo, R; Medeiros, AC; Medeiros, Vde F | 1 |
2 other study(ies) available for technetium tc 99m sestamibi and simvastatin
Article | Year |
---|---|
Statin induced myopathy does not show up in MIBI scintigraphy.
Topics: Adult; Anticholesteremic Agents; Atorvastatin; Breast Neoplasms; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heptanoic Acids; Heterozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Indoles; Lovastatin; Male; Middle Aged; Muscle, Skeletal; Muscular Diseases; Pain; Pravastatin; Pyridines; Pyrroles; Radionuclide Imaging; Radiopharmaceuticals; Simvastatin; Technetium Tc 99m Sestamibi | 2001 |
Heart and systemic effects of statin pretreatment in a rat model of abdominal sepsis. Assessment by Tc99m-sestamibi biodistribition.
Topics: Animals; Disease Models, Animal; Heart; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intraabdominal Infections; Kidney; Liver; Lung; Radionuclide Imaging; Radiopharmaceuticals; Random Allocation; Rats, Wistar; Reproducibility of Results; Sepsis; Simvastatin; Technetium Tc 99m Sestamibi; Time Factors; Treatment Outcome | 2015 |